Home

Botanik kritik parıltı adam 17 ikincil ödül evlilik

Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom  Revolution
Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution

The shedding protease ADAM17: Physiology and pathophysiology - ScienceDirect
The shedding protease ADAM17: Physiology and pathophysiology - ScienceDirect

ADAM17 Recombinant Monoclonal Antibody (3H46L1) (703077)
ADAM17 Recombinant Monoclonal Antibody (3H46L1) (703077)

Frontiers | ADAM17-Mediated Shedding of Inflammatory Cytokines in  Hypertension
Frontiers | ADAM17-Mediated Shedding of Inflammatory Cytokines in Hypertension

ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated  lung cell fusion | EMBO reports
ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion | EMBO reports

ADAM17 | Arteriosclerosis, Thrombosis, and Vascular Biology
ADAM17 | Arteriosclerosis, Thrombosis, and Vascular Biology

Contribution of ADAM17 and related ADAMs in cardiovascular diseases |  SpringerLink
Contribution of ADAM17 and related ADAMs in cardiovascular diseases | SpringerLink

FRMD8 promotes inflammatory and growth factor signalling by stabilising the  iRhom/ADAM17 sheddase complex | eLife
FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex | eLife

Control of ADAM17 activity by regulation of its cellular localisation |  Scientific Reports
Control of ADAM17 activity by regulation of its cellular localisation | Scientific Reports

The shedding protease ADAM17: Physiology and pathophysiology - ScienceDirect
The shedding protease ADAM17: Physiology and pathophysiology - ScienceDirect

The role of ADAM17 during liver damage
The role of ADAM17 during liver damage

ZLDI-8, an ADAM-17 and Notch Inhibitor, Enhances Chemotherapeutic Effects -  Network of Cancer Research
ZLDI-8, an ADAM-17 and Notch Inhibitor, Enhances Chemotherapeutic Effects - Network of Cancer Research

ADAM17 mediates cardiovascular diseases via ectodomain shedding. A... |  Download Scientific Diagram
ADAM17 mediates cardiovascular diseases via ectodomain shedding. A... | Download Scientific Diagram

Functional relevance of sADAM10 and sADAM17. Membrane-bound ADAM10 and... |  Download Scientific Diagram
Functional relevance of sADAM10 and sADAM17. Membrane-bound ADAM10 and... | Download Scientific Diagram

Contribution of ADAM17 and related ADAMs in cardiovascular diseases |  SpringerLink
Contribution of ADAM17 and related ADAMs in cardiovascular diseases | SpringerLink

JCI Insight - ADAM17 substrate release in proximal tubule drives kidney  fibrosis
JCI Insight - ADAM17 substrate release in proximal tubule drives kidney fibrosis

Molecules | Free Full-Text | Strategies to Target ADAM17 in Disease: From  Its Discovery to the iRhom Revolution
Molecules | Free Full-Text | Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution

The role of ADAM17 during liver damage
The role of ADAM17 during liver damage

ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK  Inhibitors in KRAS Mutant Colorectal Cancer: Cell Reports
ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer: Cell Reports

Frontiers | Renal ADAM10 and 17: Their Physiological and Medical Meanings
Frontiers | Renal ADAM10 and 17: Their Physiological and Medical Meanings

The shedding protease ADAM17: Physiology and pathophysiology - ScienceDirect
The shedding protease ADAM17: Physiology and pathophysiology - ScienceDirect

Frontiers | Ectodomain Shedding by ADAM17: Its Role in Neutrophil  Recruitment and the Impairment of This Process during Sepsis
Frontiers | Ectodomain Shedding by ADAM17: Its Role in Neutrophil Recruitment and the Impairment of This Process during Sepsis

Cancers | Free Full-Text | ADAM17: An Emerging Therapeutic Target for Lung  Cancer
Cancers | Free Full-Text | ADAM17: An Emerging Therapeutic Target for Lung Cancer

Recent Advances in ADAM17 Research: A Promising Target for Cancer and  Inflammation
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation